US Stock MarketDetailed Quotes
KZIA Kazia Therapeutics
- 0.288
- -0.001-0.48%
Close May 9 16:00 ET
- 0.288
- 0.0000.00%
Post 17:22 ET
7.59MMarket Cap-784P/E (TTM)
0.294High0.278Low33.31KVolume0.289Open0.289Pre Close9.51KTurnover0.15%Turnover RatioLossP/E (Static)26.36MShares1.39052wk High2.18P/B6.30MFloat Cap0.18752wk Low--Dividend TTM21.90MShs Float15.850Historical High--Div YieldTTM5.64%Amplitude0.187Historical Low0.285Avg Price1Lot Size
Kazia Therapeutics Stock Forum
Sign in to post a comment
$Kazia Therapeutics(KZIA.US$ SYDNEY, May 1, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specialising in oncology, is pleased to announce that the Safety Review Team (SRT) of the EVT801 Phase 1 clinical trial has concluded that the primary and secondary objectives of stage 1 of the trial have successfully been met. It shoulda been a weight loss drug making good advancement! It would be climbing then! Hehehe![]()
3
9
$Kazia Therapeutics(KZIA.US$ Kazia Therapeutics Ltd - Pursuant to Purchase Agreement, May Sell to Alumni Capital up to $15 Mln of American Depositary Shares From Time to Time
1
Taking a look at $Kazia Therapeutics(KZIA.US$
Here's a look at the current concensus:
Reasons to consider adding this to your portfolio:
What is the Fibonacci indicating?
Short Interest:
Remember to pay attention to the Moving Average (MA) and Volume-weighted average price (VWAP) before hoping on board!
Good Luck and Happy Trading!
Here's a look at the current concensus:
Reasons to consider adding this to your portfolio:
What is the Fibonacci indicating?
Short Interest:
Remember to pay attention to the Moving Average (MA) and Volume-weighted average price (VWAP) before hoping on board!
Good Luck and Happy Trading!
+8
$Kazia Therapeutics(KZIA.US$ Kazia Therapeutics Licenses Paxalisib To Sovargen For Intractable Seizures In Rare Central Nervous System Diseases
1
3
$Annovis Bio(ANVS.US$ 22% Ph2/3 data reporting update
$Taysha Gene Therapies(TSHA.US$ 21% FY 2023 results
$TFF Pharmaceuticals(TFFP.US$ 14% Clinical programs update
$Jaguar Health(JAGX.US$ 14% Crofelemer commercialization
$Acelyrin(SLRN.US$ 4% Ph1/2 positive data
$Delcath Systems(DCTH.US$ 3% Closes $7M private placement
$Sellas Life Sciences(SLS.US$ 0% Closes $20M offering & private placement
$Immunic(IMUX.US$ 1% Patent notice of allowance
$Nurix Therapeutics(NRIX.US$ 0...
$Taysha Gene Therapies(TSHA.US$ 21% FY 2023 results
$TFF Pharmaceuticals(TFFP.US$ 14% Clinical programs update
$Jaguar Health(JAGX.US$ 14% Crofelemer commercialization
$Acelyrin(SLRN.US$ 4% Ph1/2 positive data
$Delcath Systems(DCTH.US$ 3% Closes $7M private placement
$Sellas Life Sciences(SLS.US$ 0% Closes $20M offering & private placement
$Immunic(IMUX.US$ 1% Patent notice of allowance
$Nurix Therapeutics(NRIX.US$ 0...
10
1
In the world of biotechnology, every new development is a potential game changer, and the recent announcement by Kazia Therapeutics Limited ($KZIA) certainly fits the bill. The company has reported an early conclusion of their clinical trial after successfully reaching the primary endpoint. But what does this mean for you, the reader? Let's delve into it.
https://stockregion.app/p/therapeutics-company-reports-early
https://stockregion.app/p/therapeutics-company-reports-early
1
$Kazia Therapeutics(KZIA.US$ Kazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary Endpoint
3 MINUTES AGO, 7:30 AM EST
VIA PR NEWSWIRE
3 MINUTES AGO, 7:30 AM EST
VIA PR NEWSWIRE
3
2
Kazia's CEO, Dr. John Friend, expressed delight at the appointments, stating that Apple's deep biopharmaceutical leadership experience across finance, business development, and commercial operations will be extremely valuable for the company as it enters its next phase of growth.
$Kazia Therapeutics(KZIA.US$ Kazia Therapeutics Announces Closing of $2 Million Registered Direct Offering
PR Newswire· 3 mins ago![]()
PR Newswire· 3 mins ago
2
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Jaguar8 : It might climb later since it’s overweight issue
Stock_Drift : I’m in.
thanks
TrytosaveabitOP Stock_Drift: You’re welcome GL
Mod Tan : they just issue the prospectus, diluting shares again.
TrytosaveabitOP Mod Tan: It’s a amendment to the one filed back in February! May not have much of a affect? Need to finish updated price/amount! GL
View more comments...